Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* the patients aged 20 to 79 years with primary hypercholesterolemia that was not sufficiently responsive to therapeutic lifestyle changes and had LDL-C level over 100 mg/dL in high risk group.~* Inclusion criteria was in accordance with drug treatment guidelines; coronary artery disease or equivalent group with LDL-C ≥100 mg/dl; patients with two or more risk factors and LDL-C≥130 mg/dl; patients with 0 or 1 risk factor and LDL-C \>160 mg/dl after therapeutic lifestyle changes~Exclusion Criteria:~* therapy with any other investigational drug within 30 days of randomization,~* history of hypersensitivity to HMG-CoA reductase inhibitors,~* uncontrolled hypertension,~* poorly controlled diabetes (glycosylated hemoglobin \[HbA1c\] \>9%),~* unstable angina or presented with new-onset myocardial infarction (within 6 months),~* creatinine \>2.5 mg/dl,~* alanine aminotransferase (ALT) \>2 x upper limit of normal (ULN), aspartate aminotransferase(AST) \>2 x ULN, or creatine kinase (CK) \>2 x ULN,~* history of malignancy or psychosis;~* chronic liver disease,~* drug or alcohol abuse, pregnancy, breastfeeding, failure to practice adequate contraception, cyclical hormonal contraceptives or intermittent use of hormone replacement therapies.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Lipinon-test formulation of atrovastain - 20mg (Type: EXPERIMENTAL): None
- Lipitor- branded formuation of atorvastatin-20mg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).